Literature DB >> 17388158

PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.

Katia Parodi1, Harald Paganetti, Ethan Cascio, Jacob B Flanz, Ali A Bonab, Nathaniel M Alpert, Kevin Lohmann, Thomas Bortfeld.   

Abstract

The feasibility of off-line positron emission tomography/computed tomography (PET/CT) for routine three dimensional in-vivo treatment verification of proton radiation therapy is currently under investigation at Massachusetts General Hospital in Boston. In preparation for clinical trials, phantom experiments were carried out to investigate the sensitivity and accuracy of the method depending on irradiation and imaging parameters. Furthermore, they addressed the feasibility of PET/CT as a robust verification tool in the presence of metallic implants. These produce x-ray CT artifacts and fluence perturbations which may compromise the accuracy of treatment planning algorithms. Spread-out Bragg peak proton fields were delivered to different phantoms consisting of polymethylmethacrylate (PMMA), PMMA stacked with lung and bone equivalent materials, and PMMA with titanium rods to mimic implants in patients. PET data were acquired in list mode starting within 20 min after irradiation at a commercial luthetium-oxyorthosilicate (LSO)-based PET/CT scanner. The amount and spatial distribution of the measured activity could be well reproduced by calculations based on the GEANT4 and FLUKA Monte Carlo codes. This phantom study supports the potential of millimeter accuracy for range monitoring and lateral field position verification even after low therapeutic dose exposures of 2 Gy, despite the delay between irradiation and imaging. It also indicates the value of PET for treatment verification in the presence of metallic implants, demonstrating a higher sensitivity to fluence perturbations in comparison to a commercial analytical treatment planning system. Finally, it addresses the suitability of LSO-based PET detectors for hadron therapy monitoring. This unconventional application of PET involves countrates which are orders of magnitude lower than in diagnostic tracer imaging, i.e., the signal of interest is comparable to the noise originating from the intrinsic radioactivity of the detector itself. In addition to PET alone, PET/CT imaging provides accurate information on the position of the imaged object and may assess possible anatomical changes during fractionated radiotherapy in clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388158      PMCID: PMC2292642          DOI: 10.1118/1.2401042

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  24 in total

1.  Relation between carbon ion ranges and x-ray CT numbers.

Authors:  O Jäkel; C Jacob; D Schardt; C P Karger; G H Hartmann
Journal:  Med Phys       Date:  2001-04       Impact factor: 4.071

2.  Test of GEANT3 and GEANT4 nuclear models for 160 MeV protons stopping in CH2.

Authors:  H Paganetti; B Gottschalk
Journal:  Med Phys       Date:  2003-07       Impact factor: 4.071

3.  PET performance measurements for an LSO-based combined PET/CT scanner using the National Electrical Manufacturers Association NU 2-2001 standard.

Authors:  Yusuf E Erdi; Sadek A Nehmeh; Tim Mulnix; John L Humm; Charles C Watson
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

4.  NEMA NU 2 performance tests for scanners with intrinsic radioactivity.

Authors:  Charles C Watson; Michael E Casey; Lars Eriksson; Tim Mulnix; Doug Adams; Bernard Bendriem
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

5.  Formation of short-lived positron emitters in reactions of protons of energies up to 200 MeV with the target elements carbon, nitrogen and oxygen.

Authors:  K Kettern; Yu N Shubin; G F Steyn; T N Van Der Walt; H H Coenen; S M Qaim
Journal:  Appl Radiat Isot       Date:  2004-06       Impact factor: 1.513

6.  Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility.

Authors:  H Paganetti; H Jiang; S Y Lee; H M Kooy
Journal:  Med Phys       Date:  2004-07       Impact factor: 4.071

7.  Adaptation of GEANT4 to Monte Carlo dose calculations based on CT data.

Authors:  H Jiang; H Paganetti
Journal:  Med Phys       Date:  2004-10       Impact factor: 4.071

8.  Dose quantification from in-beam positron emission tomography.

Authors:  W Enghardt; K Parodi; P Crespo; F Fiedler; J Pawelke; F Pönisch
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

9.  Production of 13N radioactive nuclei from 13C(p,n) or 16O(p, alpha ) reactions.

Authors: 
Journal:  Phys Rev C Nucl Phys       Date:  1989-07

10.  The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power.

Authors:  B Schaffner; E Pedroni
Journal:  Phys Med Biol       Date:  1998-06       Impact factor: 3.609

View more
  22 in total

1.  Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry.

Authors:  Xuping Zhu; Timothy G Reese; Elizabeth M Crowley; Georges El Fakhri
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

2.  Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.

Authors:  K Parodi; A Ferrari; F Sommerer; H Paganetti
Journal:  Phys Med Biol       Date:  2007-05-17       Impact factor: 3.609

3.  Monitoring proton radiation therapy with in-room PET imaging.

Authors:  Xuping Zhu; Samuel España; Juliane Daartz; Norbert Liebsch; Jinsong Ouyang; Harald Paganetti; Thomas R Bortfeld; Georges El Fakhri
Journal:  Phys Med Biol       Date:  2011-06-15       Impact factor: 3.609

4.  Mapping (15)O production rate for proton therapy verification.

Authors:  Kira Grogg; Nathaniel M Alpert; Xuping Zhu; Chul Hee Min; Mauro Testa; Brian Winey; Marc D Normandin; Helen A Shih; Harald Paganetti; Thomas Bortfeld; Georges El Fakhri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-25       Impact factor: 7.038

5.  Proton therapy dosimetry using positron emission tomography.

Authors:  Matthew T Studenski; Ying Xiao
Journal:  World J Radiol       Date:  2010-04-28

6.  Dosimetric accuracy of proton therapy for chordoma patients with titanium implants.

Authors:  Joost M Verburg; Joao Seco
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

7.  The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy.

Authors:  S España; X Zhu; J Daartz; G El Fakhri; T Bortfeld; H Paganetti
Journal:  Phys Med Biol       Date:  2011-04-05       Impact factor: 3.609

8.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

9.  Determination of elemental tissue composition following proton treatment using positron emission tomography.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Chul Hee Min; Xuping Zhu; Georges El Fakhri; Harald Paganetti; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-05-16       Impact factor: 3.609

10.  Current concepts on imaging in radiotherapy.

Authors:  Michela Lecchi; Piero Fossati; Federica Elisei; Roberto Orecchia; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-31       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.